Knowledge of the natural history and genotype–phenotype correlation of GLB1-related conditions associated with the various types of dysostosis multiplex are essential to establishing appropriate nomenclature for GLB1-related dysostoses, and to inform the design and choice of outcomes in future clinical trials. The gene discussed is GLB1; the disease is dysostosis.